Heather E. Grant

Heather E. Grant

Auto-generated profile, based on publicly available information

Heather E. Grant

Centre for Evolution and Cancer, Institute of Cancer Research, London, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2025 in Nature
Verified
Journal Article
Open access
PDF file
CGCalum Gabbutt
Calum Gabbutt
MDMartí Duran-Ferrer
Martí Duran-Ferrer
HGHeather E. Grant
Heather E. Grant
DMDiego Mallo
Diego Mallo
FNFerran Nadeu
Ferran Nadeu
TGTrevor Graham
Trevor Graham
Cancer development and response to treatment are evolutionary processes1,2, but characterizing evolutionary dynamics at a clinically meaningful scale has remained challenging3. Here we develop a new methodology called EVOFLUx, based on natural DNA methylation barcodes fluctuating over time4, that quantitatively infers evolutionary dynamics using only a bulk tumour methylation profile as input. We apply EVOFLUx to 1,976 well-characterized lymphoid cancer samples spanning a broad spectrum of diseases and show that initial tumour growth rate, malignancy age and epimutation rates vary by orders of magnitude across disease types. We measure that subclonal selection occurs only infrequently within bulk samples and detect occasional examples of multiple independent primary tumours. Clinically, we observe faster initial tumour growth in more aggressive disease subtypes, and that evolutionary histories are strong independent prognostic factors in two series of chronic lymphocytic leukaemia. Using EVOFLUx for phylogenetic analyses of aggressive Richter-transformed chronic lymphocytic leukaemia samples detected that the seed of the transformed clone existed decades before presentation. Orthogonal verification of EVOFLUx inferences is provided using additional genetic data, including long-read nanopore sequencing, and clinical variables. Collectively, we show how widely available, low-cost bulk DNA methylation data precisely measure cancer evolutionary dynamics, and provides new insights into cancer biology and clinical behaviour.

1 January 2020 in Virus Evolution
Verified
Journal Article
Open access
PDF file
HGHeather E Grant
Heather E Grant
EHEmma B. Hodcroft
Emma B. Hodcroft
DSDeogratius Ssemwanga
Deogratius Ssemwanga
John Mulindwa KitayimbwaJohn Mulindwa Kitayimbwa
John Mulindwa Kitayimbwa
GYGonzalo Yebra
Gonzalo Yebra
ABAndrew J. Leigh Brown
Andrew J. Leigh Brown
Recombination is an important feature of HIV evolution, occurring both within and between the major branches of diversity (subtypes). The Ugandan epidemic is primarily composed of two subtypes, A1 and D, that have been co-circulating for 50 years, frequently recombining in dually infected patients. Here, we investigate the frequency of recombinants in this population and the location of breakpoints along the genome. As part of the PANGEA-HIV consortium, 1,472 consensus genome sequences over 5 kb have been obtained from 1,857 samples collected by the MRC/UVRI & LSHTM Research unit in Uganda, 465 (31.6 per cent) of which were near full-length sequences (>8 kb). Using the subtyping tool SCUEAL, we find that of the near full-length dataset, 233 (50.1 per cent) genomes contained only one subtype, 30.8 per cent A1 (n = 143), 17.6 per cent D (n = 82), and 1.7 per cent C (n = 8), while 49.9 per cent (n = 232) contained more than one subtype (including A1/D (n = 164), A1/C (n = 13), C/D (n = 9); A1/C/D (n = 13), and 33 complex types). K-means clustering of the recombinant A1/D genomes revealed a section of envelope (C2gp120-TMgp41) is often inherited intact, whilst a generalized linear model was used to demonstrate significantly fewer breakpoints in the gag–pol and envelope C2-TM regions compared with accessory gene regions. Despite similar recombination patterns in many recombinants, no clearly supported circulating recombinant form (CRF) was found, there was limited evidence of the transmission of breakpoints, and the vast majority (153/164; 93 per cent) of the A1/D recombinants appear to be unique recombinant forms. Thus, recombination is pervasive with clear biases in breakpoint location, but CRFs are not a significant feature, characteristic of a complex, and diverse epidemic.

8 November 2023 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Closed access
HGHeather E. Grant
Heather E. Grant
AOAndrew N. Ostrovsky
Andrew N. Ostrovsky
HJHelen L. Jenkins
Helen L. Jenkins
LVLeandro M. Vieira
Leandro M. Vieira
DGDennis P. Gordon
Dennis P. Gordon
AWAndrea Waeschenbach
Andrea Waeschenbach
Parental care is considered crucial for the enhanced survival of offspring and evolutionary success of many metazoan groups. Most bryozoans incubate their young in brood chambers or intracoelomically. Based on the drastic morphological differences in incubation chambers across members of the order Cheilostomatida (class Gymnolaemata), multiple origins of incubation were predicted in this group. This hypothesis was tested by constructing a molecular phylogeny based on mitogenome data and nuclear rRNA genes 18S and 28S with the most complete sampling of taxa with various incubation devices to date. Ancestral character estimation suggested that distinct types of brood chambers evolved at least 10 times in Cheilostomatida. In Eucratea loricata and Aetea spp. brooding evolved unambiguously from a zygote-spawning ancestral state, as it probably did in Tendra zostericola , Neocheilostomata, and ‘Carbasea' indivisa . In two further instances, brooders with different incubation chamber types, skeletal and non-skeletal, formed clades ( Scruparia spp., Leiosalpinx australis ) and ( Catenicula corbulifera ( Steginoporella spp. ( Labioporella spp., Thalamoporella californica ))), each also probably evolved from a zygote-spawning ancestral state. The modular nature of bryozoans probably contributed to the evolution of such a diverse array of embryonic incubation chambers, which included complex constructions made of polymorphic heterozooids, and maternal zooidal invaginations and outgrowths.

2 May 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AOAbayomi S. Olabode
Abayomi S. Olabode
GNGarway T. Ng
Garway T. Ng
KWKaitlyn E. Wade
Kaitlyn E. Wade
MSMikhail Salnikov
Mikhail Salnikov
HGHeather E. Grant
Heather E. Grant
APArt F. Y. Poon
Art F. Y. Poon
Significance: Recombination is a major mechanism through which HIV type 1 (HIV-1) maintains genetic diversity and interferes with viral eradication efforts. There is growing evidence demonstrating a recombinant origin of primate lentiviruses including HIV-1 group M (HIV-1/M). Inferring the extent of recombination across the entire HIV-1/M genome is of great importance as it provides deeper insights into the origin, dynamics, and evolution of the global pandemic. Here we propose an alternative method that can reconstruct the extent of genome-wide recombination in HIV-1, uncover reticulate patterns, and serve as a framework for HIV-1 classification. Our method provides an alternative approach for understanding the roles of virus recombination in the early evolutionary history of zoonosis for other emerging viruses.

29 July 2022 in Viruses
Verified
Journal Article
Open access
PDF file
EPEmma Pujol-Hodge
Emma Pujol-Hodge
JSJesus F. Salazar-Gonzalez
Jesus F. Salazar-Gonzalez
DSDeogratius Ssemwanga
Deogratius Ssemwanga
ECEdwin D. Charlebois
Edwin D. Charlebois
James AyiekoJames Ayieko
James Ayieko
ABAndrew J. Leigh Brown
Andrew J. Leigh Brown
The Sustainable East Africa Research in Community Health (SEARCH) trial was a universal test-and-treat (UTT) trial in rural Uganda and Kenya, aiming to lower regional HIV-1 incidence. Here, we quantify breakthrough HIV-1 transmissions occurring during the trial from population-based, dried blood spot samples. Between 2013 and 2017, we obtained 549 gag and 488 pol HIV-1 consensus sequences from 745 participants: 469 participants infected prior to trial commencement and 276 SEARCH-incident infections. Putative transmission clusters, with a 1.5% pairwise genetic distance threshold, were inferred from maximum likelihood phylogenies; clusters arising after the start of SEARCH were identified with Bayesian time-calibrated phylogenies. Our phylodynamic approach identified nine clusters arising after the SEARCH start date: eight pairs and one triplet, representing mostly opposite-gender linked (6/9), within-community transmissions (7/9). Two clusters contained individuals with non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance, both linked to intervention communities. The identification of SEARCH-incident, within-community transmissions reveals the role of unsuppressed individuals in sustaining the epidemic in both arms of a UTT trial setting. The presence of transmitted NNRTI resistance, implying treatment failure to the efavirenz-based antiretroviral therapy (ART) used during SEARCH, highlights the need to improve delivery and adherence to up-to-date ART recommendations, to halt HIV-1 transmission.

10 November 2023 in medRxiv
Verified
Preprint
Open access
PDF file
CGCalum Gabbutt
Calum Gabbutt
MDMartí Duran-Ferrer
Martí Duran-Ferrer
HGHeather Grant
Heather Grant
DMDiego Mallo
Diego Mallo
FNFerran Nadeu
Ferran Nadeu
TGTrevor Graham
Trevor Graham
Cancer development, progression, and response to treatment are evolutionary processes, but characterising the evolutionary dynamics at sufficient scale to be clinically-meaningful has remained challenging. Here, we develop a new methodology called EVOFLUx, based upon natural DNA methylation barcodes fluctuating over time, that quantitatively infers evolutionary dynamics using only a bulk tumour methylation profile as input. We apply EVOFLUx to 1,976 well-characterised lymphoid cancer samples spanning a broad spectrum of diseases and show that tumour growth rates, malignancy age and epimutation rates vary by orders of magnitude across disease types. We measure that subclonal selection occurs only infrequently within bulk samples and detect occasional examples of multiple independent primary tumours. Clinically, we observe that tumour growth rates are higher in more aggressive disease subtypes, and in two series of chronic lymphocytic leukaemia patients, evolutionary histories are independent prognostic factors. Phylogenetic analyses of longitudinal CLL samples using EVOFLUx detect the seeds of future Richter transformation many decades prior to presentation. We provide orthogonal verification of EVOFLUx inferences using additional genetic and clinical data. Collectively, we show how widely- available, low-cost bulk DNA methylation data precisely measures cancer evolutionary dynamics, and provides new insights into cancer biology and clinical behaviour.